Table: begin end state 1 25 signal peptide 26 27 transmembrane 28 38 non-cytoplasmic 39 59 transmembrane 60 81 cytoplasmic 82 102 transmembrane 103 120 non-cytoplasmic 121 139 transmembrane 140 148 cytoplasmic 149 168 transmembrane 169 181 non-cytoplasmic 182 205 transmembrane 206 217 cytoplasmic 218 236 transmembrane 237 270 non-cytoplasmic 271 296 transmembrane 297 308 cytoplasmic 309 327 transmembrane 328 332 non-cytoplasmic 333 355 transmembrane 356 370 cytoplasmic 371 393 transmembrane 394 395 non-cytoplasmic
Input: >201222 FitnessBrowser__MR1:201222 MTQNKFFGSLLLIAGTTIGAGMLALPIASAGLGFGMSSMIMLIFWALMAYTALLMVEIHQ FAPSDASLNQLARHLLGTKGQVVACIALMFLLYALCAAYIAGGGEQVHQKLTSWLGLALP PQAGAILFTLLIGTIVGLGTHCVDLINRVLFSLKIIALILMLALLLPQVEGTHLLELPLE QGLIVSAIPVIFTSFGFHGSIPSVVRYLGIEVKALRKIMLLGSALPLLIYLLWQLGSQGV LSQSQLMTNQSLSGFISQLASVLHSQYLSSAISVFADLALATSFLGVSLGLFDFIAANLR QEDNATGRSVTAAITFVPPLGFALFYPQGFITALGYAAIALVILAIFLPVSMVWVQRKQR DKAKLPQGYRVAGGTLGLVLALLCGLAVISAQLLG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server